Pharmacokinetic Properties of a Novel Gastric Proton Pump Inhibitor, (±)-2-[(4-Methoxy-6,7,8,9-Tetrahydro-5h-Cyclohepta[d]Pyridin-9-yl) Sulfinyl]-1h-Benzimidazole Sodium Salt, in Healthy Subjects

This publication has 7 references indexed in Scilit:

• Pharmacological Analysis of Receptors Involved in the Late, Tachykininergic Contractile Response to Electrical Transmural Stimulation in Isolated Rabbit Iris Sphincter Muscle
  The Japanese Journal of Pharmacology, 1993
• Lansoprazole
  Drugs, 1992
• Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells
  Biochemical Pharmacology, 1991
• Ro 18-5364, a potent new inhibitor of the gastric (H+ + K+)-ATPase
  European Journal of Biochemistry, 1987
• Pharmacokinetics and metabolism of omeprazole in animals and man - an overview
  Scandinavian Journal of Gastroenterology, 1985
• Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
  Gut, 1983
• Influence of Food on the Bioavailability of Drugs
  Clinical Pharmacokinetics, 1978